Neurol. praxi. 2011;12(2):129-134

Complications of ischaemic stroke

doc.MUDr.Edvard Ehler, CSc., MUDr.Aleš Kopal, MSN Petra Mandysová, MUDr.Ján Latta
Neurologická klinika PKN a FZS Univerzity Pardubice

Patients with ischemic cerebrovascular accident (CVA) can develop complications. About 30 % of patients experience progression of

focal or global brain changes. In this case, the CVA is progressive, which is a neurological complication. As a general rule, complications

affecting organ systems other than just the brain are called medical complications. They occur both in the acute stage of ischemic CVA,

due to pathological changes existing already before a CVA occurs (e. g., hypertension, diabetes mellitus, and ischemic heart disease), and

in association with the type and severity of a CVA (impairment of consciousness, edema). In the first week, complications of the acute

phase of a CVA can develop (such as confusion, negativism, dysphagia, phlebothrombosis, and pressure sores). After the resolution of

the acute stage, there is a rising incidence of other complications (depression, spasticity, undernutrition, and falls). It is necessary to

know the complications, their risk factors, and their timing in relation to stroke, and based on this knowledge, to implement preventive

measures and sensible therapy.

Keywords: progressive CVA, medical complication, falls, spasticity, pressure ulcers, dysphagia

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E, Kopal A, Petra Mandysová M, Latta J. Complications of ischaemic stroke. Neurol. praxi. 2011;12(2):129-134.
Download citation

References

  1. Ashburn A, Hyndman D, Pickering R, Yardley L, Harris S. Predicting people with stroke at risk of falls. Age and ageing 2008; 37: 270-276. Go to original source... Go to PubMed...
  2. Baldwin RC, Preventing late-life depression: a clinical update. Internat Psychogeriatrics 2010; 22: 1216-1224. Go to original source... Go to PubMed...
  3. Bauer J. Antikoagulační terapie v prevenci a léčbě ischemických iktů. Cesk Slov Neurol N 2010; 73/106(5): 480-491.
  4. Brainin M, Heiss W-D. Textbook of stroke medicine. Cambridge: Cambridge University Press 2010: 326. Go to original source...
  5. Chin PS, Branch KR, Becker KJ. Postictal neurogenic stunned myocardium. Neurology 2005; 64: 1977-1978. Go to original source... Go to PubMed...
  6. García-Peris P, Parón L, Velasco C, de la Cuerda C, Camblor M, Bretón I, Herencia H, Verdaguer J, Navarro C, Clave P. Longterm prevalence of oropharyngeal dysphagia in head and neck cancer patients: Impact on quality of life. Clin Nutr 2007; 26(6): 710-717. Go to original source... Go to PubMed...
  7. Herzig R, Školoudík D, Šaňák D. Management ischemické cévní mozkové příhody a transitorní ischemické ataky - doporučení European Stroke Organisation (ESO) 2008. Neurol pro praxi 2008; 9: 261-266.
  8. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S. Formal dysphagia screening protocols prevent pneumonia. Stroke 2005; 36: 1972-1976. Go to original source... Go to PubMed...
  9. Hong KS, Kang DW, Koo JS, Yu KH, Han MK. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. J Neurol 2008; 15: 1324-1331. Go to original source... Go to PubMed...
  10. Ingeman A, Andersen G, Hundborg HH, Svendsen ML, Johnsen SP. Processes of care and medical complications in patiens with stroke. Stroke 2011; 42: 167-172. Go to original source... Go to PubMed...
  11. Kalvach P, a kol. Mozkové ischemie a hemoragie. 3rd edition. Praha: Grada Publishing 2010: 456.
  12. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurology 2010; 9: 105-118. Go to original source... Go to PubMed...
  13. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: Incidence, diagnosis, and pulmonary complications. Stroke 2005; 36: 2756-2763. Go to original source... Go to PubMed...
  14. Muir KW. The PREVAIL trial and low-molecular-weight heparin for prevention of venous thrombembolism. Stroke 2008; 39: 2174-2176. Go to original source... Go to PubMed...
  15. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L. Medical complications after stroke: a multicenter study. Stroke 2000; 31: 1223-1233. Go to original source... Go to PubMed...
  16. Liao J, O´Donnel MJ, Silver FL, Thiruchelvam D, Saposnik G. In-hospital myocardial infarction following acute ischaemic stroke: an observational study. J Neurol 2009; 18: 1035-1040. Go to original source... Go to PubMed...
  17. Smout J. Macdonald S, Weir G, Stensby G. Carotid artery stenting: Relationship betrween experience and complication rate. Internat J Stroke 2010; 5: 477-482. Go to original source... Go to PubMed...
  18. Snaphaan L, Van Der Werf S, De Leeuw FE. Time course and risk factors of post-stroke fatigue: a prospective cohort. E J Neurology 2010; 2010 Sep 27. doi: 10.1111/j.14681331.2010.03217. Go to original source...
  19. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W; DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infaction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 215-222. Go to original source... Go to PubMed...
  20. Warlow CP, Dennis MS, van Gijn J, Hankey GJ, Sandercock PAG, Bamford JM, Wardlav J. Stroke. A practical guide to management.Oxford: Blackwell Science 1996: 664.
  21. Weimar C, Roth MP, Zillessen G, Glahn J. Complications following acute ischemic stroke. Europ Neur 2002; 48: 133-141. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.